← Back to signals
TMO
LONGINSIDER SELLTHERMO FISHER SCIENTIFIC INC
Funds
4
Score
5.25
vs SPY
-16.1%
Stock return (since Q-end)
+0.2%
SPY return (since Q-end)
+16.3%
Current price
$492.51
News Summary
NegativeTMO reported Q1 2026 earnings beats on headline metrics (EPS +11%, revenue +6%) with raised full-year guidance ($24.64–$25.12 adjusted EPS, $47.3–$48.1B revenue), but underlying organic growth of only 1% disappointed investors, triggering a 7.5% intraday selloff. The company is executing a strategic pivot toward biopharma (Clario $8.9B acquisition, $1.075B microbiology divestiture) while facing macro headwinds in diagnostics and academia, with shareholder discontent over executive compensation also evident.
Red flags
- •Organic revenue growth of 1% significantly below consensus expectations, with weak diagnostics segment (-3% organic) and academic/government revenue declines
- •Stock down ~20% since January 31, 2026, trading at $473 vs. 52-week high of $644, indicating sustained investor skepticism
- •Shareholder advisory vote on executive compensation rejected with 214.5M votes against vs. 99.9M for—rare governance red flag signaling pay practice concerns
- •Microbiology divestiture ($1.075B sale to Astorg) dilutive by $0.15 EPS in first full year post-close; ongoing divestitures creating near-term EPS headwinds per analyst commentary
- •Muted macro conditions cited across U.S. and China markets; mid-single-digit revenue decline in diagnostics/healthcare segment due to weak respiratory season
- •Analyst price targets revised downward ~6% in past 3 months; Morgan Stanley cut target from $670 to $620 despite maintaining Overweight rating
Funds Buying (4)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | QoQ | Status |
|---|---|---|---|---|---|---|
| Viking Global | Andreas Halvorsen | 1.7M | +875K | $819.9B | +110% | Existing |
| D1 Capital | Dan Sundheim | 725K | +725K | $356.4B | — | NEW |
| Point72 | Steve Cohen | 354K | +354K | $173.8B | — | NEW |
| Glenview Capital | Larry Robbins | 251K | +27K | $123.1B | +12% | Existing |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|
| Pettiti Gianluca | President & COO | SELL | 400 | $462.66 | $0.19M | 2026-04-27 |